These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38326472)

  • 1. Brain glucose mediates amphotericin B tolerance.
    Crunkhorn S
    Nat Rev Drug Discov; 2024 Mar; 23(3):174. PubMed ID: 38326472
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of amphotericin B with azole antifungal drugs: what are we doing?
    Sugar AM
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1907-12. PubMed ID: 8540690
    [No Abstract]   [Full Text] [Related]  

  • 3. Amphotericin intravenous preparations.
    MacConnachie AM
    Intensive Crit Care Nurs; 1997 Jun; 13(3):173-4. PubMed ID: 9287582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal agents used for deep-seated mycotic infections.
    Hermans PE; Keys TF
    Mayo Clin Proc; 1983 Apr; 58(4):223-31. PubMed ID: 6339832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.
    Moosa MY; Alangaden GJ; Manavathu E; Chandrasekar PH
    J Antimicrob Chemother; 2002 Jan; 49(1):209-13. PubMed ID: 11751792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B still in the headlines.
    Romani L
    Pathog Glob Health; 2012 May; 106(2):80-1. PubMed ID: 22943542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antifungal activity and clinical efficacy of liposomal amphotericin B (AmBisome)].
    Maniwa T; Yamamoto Y
    Nihon Yakurigaku Zasshi; 2007 Feb; 129(2):129-34. PubMed ID: 17299241
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia.
    Clancy CJ; Nguyen MH
    Antimicrob Agents Chemother; 1999 May; 43(5):1289-90. PubMed ID: 10223955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B: an update.
    Abu-Salah KM
    Br J Biomed Sci; 1996 Jun; 53(2):122-33. PubMed ID: 8757689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lysosomotropic form of amphotericin B on functional state of phagocytes in experimental candidiasis.
    Kurilin VV; Saperova MA; Efanov EA; Tsyrendorzhiev DD; Shkurupiy VA
    Bull Exp Biol Med; 2008 Dec; 146(6):698-700. PubMed ID: 19513358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B use in children: conventional and lipid-based formulations.
    Kuyucu N
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):357-67. PubMed ID: 21417875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspergillus nidulans is frequently resistant to amphotericin B.
    Kontoyiannis DP; Lewis RE; May GS; Osherov N; Rinaldi MG
    Mycoses; 2002 Nov; 45(9-10):406-7. PubMed ID: 12421291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough fungemia appearing during empiric therapy with amphotericin B.
    Krcméry V; Spanik S; Kunova A; Trupl J
    Chemotherapy; 1997; 43(5):367-70. PubMed ID: 9309371
    [No Abstract]   [Full Text] [Related]  

  • 14. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
    Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Caspofungin in the replacement of amphotericin B in the treatment of fungal diseases].
    Yang W; He B
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):53. PubMed ID: 15808079
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis.
    Larsen RA; Bauer M; Brouwer AE; Sanchez A; Thomas AM; Rajanuwong A; Chierakul W; Peacock SJ; Day N; White NJ; Rinaldi MG; Harrison TS
    Antimicrob Agents Chemother; 2007 Jan; 51(1):343-5. PubMed ID: 17060519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191.
    Graybill JR; Kaster SR
    Am Rev Respir Dis; 1984 Feb; 129(2):292-5. PubMed ID: 6364905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.
    Dannaoui E; Meletiadis J; Tortorano AM; Symoens F; Nolard N; Viviani MA; Piens MA; Lebeau B; Verweij PE; Grillot R; And The Ebga Network
    J Med Microbiol; 2004 Feb; 53(Pt 2):129-134. PubMed ID: 14729934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
    Rabinovich S; Shaw BD; Bryant T; Donta ST
    J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal drugs.
    Cross JT; Hickerson SL; Yamauchi T
    Pediatr Rev; 1995 Apr; 16(4):123-9. PubMed ID: 7731906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.